Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies
Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial
obstruction increases pulmonary vascular resistance, which leads to right ventricular (RV) …
obstruction increases pulmonary vascular resistance, which leads to right ventricular (RV) …
Pulmonary arterial hypertension–progress in understanding the disease and prioritizing strategies for drug development
P Ghataorhe, CJ Rhodes, L Harbaum… - Journal of Internal …, 2017 - Wiley Online Library
Pulmonary arterial hypertension (PAH), at one time a largely overlooked disease, is now the
subject of intense study in many academic and biotech groups. The availability of new …
subject of intense study in many academic and biotech groups. The availability of new …
[HTML][HTML] Pulmonary arterial hypertension management in asia: state of the art from Japan, and next steps
E Fung - JACC: Asia, 2022 - jacc.org
Pulmonary arterial hypertension (PAH) is a relatively rare disease and comprises a group of
progressive vascular disorders that may result in functional debilitation, cardiopulmonary …
progressive vascular disorders that may result in functional debilitation, cardiopulmonary …
Novel experimental therapies for treatment of pulmonary arterial hypertension
R Zolty - Journal of Experimental Pharmacology, 2021 - Taylor & Francis
Pulmonary arterial hypertension (PAH) is a progressive and devastating disease
characterized by pulmonary artery vasoconstriction and vascular remodeling leading to …
characterized by pulmonary artery vasoconstriction and vascular remodeling leading to …
New drugs and therapies in pulmonary arterial hypertension
Pulmonary arterial hypertension is a chronic, progressive disorder of the pulmonary
vasculature with associated pulmonary and cardiac remodeling. PAH was a uniformly fatal …
vasculature with associated pulmonary and cardiac remodeling. PAH was a uniformly fatal …
Molecular genetic framework underlying pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a rare, progressive disorder typified by occlusion
of the pulmonary arterioles owing to endothelial dysfunction and uncontrolled proliferation of …
of the pulmonary arterioles owing to endothelial dysfunction and uncontrolled proliferation of …
Pulmonary hypertension care centers
M Chakinala, M McGoon - Advances in Pulmonary …, 2014 - meridian.allenpress.com
Our understanding and management of pulmonary arterial hypertension (PAH) has
advanced tremendously over the last 30 years. Numerous scientific discoveries have helped …
advanced tremendously over the last 30 years. Numerous scientific discoveries have helped …
Pulmonary arterial hypertension: diagnosis, treatment, and novel advances
The diagnosis and management of pulmonary arterial hypertension (PAH) includes several
advances, such as a broader recognition of extrapulmonary vascular organ system …
advances, such as a broader recognition of extrapulmonary vascular organ system …
An expanding role of biomarkers in pulmonary arterial hypertension
M Yildiz, A Sahin, M Behnes… - Current Pharmaceutical …, 2017 - ingentaconnect.com
Background: Pulmonary Arterial Hypertension (PAH) is a chronic disease which may cause
or result from multiple cardiopulmonary disorders. The disease has complex …
or result from multiple cardiopulmonary disorders. The disease has complex …
A review of pulmonary arterial hypertension: Part 1. Novel insights and classification
CT Gan, AV Noordegraaf, KMJ Marques… - Netherlands Heart …, 2004 - ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is a disease characterised by an increased
pulmonary artery pressure. The precapillary pulmonary arteries show distinct …
pulmonary artery pressure. The precapillary pulmonary arteries show distinct …